SE466308B - Kinolinderivat - Google Patents
KinolinderivatInfo
- Publication number
- SE466308B SE466308B SE8602524A SE8602524A SE466308B SE 466308 B SE466308 B SE 466308B SE 8602524 A SE8602524 A SE 8602524A SE 8602524 A SE8602524 A SE 8602524A SE 466308 B SE466308 B SE 466308B
- Authority
- SE
- Sweden
- Prior art keywords
- general formula
- acid addition
- lower alkyl
- compound
- radiation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU852193A HU195487B (en) | 1985-06-04 | 1985-06-04 | Process for producing quinoline derivatives |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8602524D0 SE8602524D0 (sv) | 1986-06-04 |
SE8602524L SE8602524L (sv) | 1986-12-05 |
SE466308B true SE466308B (sv) | 1992-01-27 |
Family
ID=10958222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8602524A SE466308B (sv) | 1985-06-04 | 1986-06-04 | Kinolinderivat |
Country Status (28)
Country | Link |
---|---|
US (1) | US4652562A (es) |
JP (1) | JPS6248668A (es) |
KR (1) | KR930006775B1 (es) |
CN (1) | CN1012957B (es) |
AT (1) | AT392469B (es) |
AU (1) | AU588883B2 (es) |
BE (1) | BE904864A (es) |
CA (1) | CA1266650A (es) |
CH (1) | CH668069A5 (es) |
CS (1) | CS257793B2 (es) |
DD (1) | DD247448A5 (es) |
DE (1) | DE3618724C2 (es) |
DK (1) | DK162841C (es) |
ES (1) | ES8707231A1 (es) |
FI (1) | FI82451C (es) |
FR (1) | FR2582835B1 (es) |
GB (1) | GB2176185B (es) |
GR (1) | GR861452B (es) |
HU (1) | HU195487B (es) |
IL (1) | IL79024A0 (es) |
IT (1) | IT1204377B (es) |
NL (1) | NL8601434A (es) |
NO (1) | NO165635C (es) |
PH (1) | PH24135A (es) |
PL (1) | PL146498B1 (es) |
PT (1) | PT82712B (es) |
SE (1) | SE466308B (es) |
SU (1) | SU1398773A3 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6331286B1 (en) | 1998-12-21 | 2001-12-18 | Photogen, Inc. | Methods for high energy phototherapeutics |
US8974363B2 (en) * | 1997-12-11 | 2015-03-10 | Provectus Pharmatech, Inc. | Topical medicaments and methods for photodynamic treatment of disease |
US20090117199A1 (en) * | 1998-08-06 | 2009-05-07 | Scott Timothy C | Method of treatment of cancer |
US8557298B2 (en) * | 1998-08-06 | 2013-10-15 | Provectus Pharmatech, Inc. | Medicaments for chemotherapeutic treatment of disease |
US8470296B2 (en) * | 1998-12-21 | 2013-06-25 | Provectus Pharmatech, Inc. | Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
US7384623B1 (en) | 1998-12-21 | 2008-06-10 | Provectus Pharmatech, Inc. | High energy phototherapeutic agents |
US20020001567A1 (en) * | 1998-12-21 | 2002-01-03 | Photogen, Inc. | Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
EP1719770A3 (en) * | 2000-09-21 | 2008-03-05 | Smithkline Beecham Plc | Quinoline derivatives as antibacterials |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU165520B (es) * | 1972-05-05 | 1974-09-28 | ||
IE47458B1 (en) * | 1977-11-07 | 1984-03-21 | Leo Pharm Prod Ltd | Quinolylguanidine derivatives |
-
1985
- 1985-06-04 HU HU852193A patent/HU195487B/hu not_active IP Right Cessation
-
1986
- 1986-05-28 CH CH2153/86A patent/CH668069A5/de not_active IP Right Cessation
- 1986-05-30 DD DD86290766A patent/DD247448A5/de not_active IP Right Cessation
- 1986-06-03 BE BE0/216734A patent/BE904864A/fr not_active IP Right Cessation
- 1986-06-03 PH PH33848A patent/PH24135A/en unknown
- 1986-06-03 CN CN86103688A patent/CN1012957B/zh not_active Expired
- 1986-06-03 AT AT1492/86A patent/AT392469B/de not_active IP Right Cessation
- 1986-06-03 KR KR1019860004409A patent/KR930006775B1/ko not_active IP Right Cessation
- 1986-06-04 IL IL79024A patent/IL79024A0/xx not_active IP Right Cessation
- 1986-06-04 GR GR861452A patent/GR861452B/el unknown
- 1986-06-04 NL NL8601434A patent/NL8601434A/nl not_active Application Discontinuation
- 1986-06-04 CA CA000510779A patent/CA1266650A/en not_active Expired - Lifetime
- 1986-06-04 US US06/870,396 patent/US4652562A/en not_active Expired - Fee Related
- 1986-06-04 DE DE3618724A patent/DE3618724C2/de not_active Expired - Fee Related
- 1986-06-04 PT PT82712A patent/PT82712B/pt unknown
- 1986-06-04 SE SE8602524A patent/SE466308B/sv not_active IP Right Cessation
- 1986-06-04 FI FI862381A patent/FI82451C/fi not_active IP Right Cessation
- 1986-06-04 ES ES555708A patent/ES8707231A1/es not_active Expired
- 1986-06-04 DK DK262186A patent/DK162841C/da not_active IP Right Cessation
- 1986-06-04 JP JP61130006A patent/JPS6248668A/ja active Granted
- 1986-06-04 NO NO862230A patent/NO165635C/no unknown
- 1986-06-04 SU SU864027590A patent/SU1398773A3/ru active
- 1986-06-04 CS CS864112A patent/CS257793B2/cs unknown
- 1986-06-04 AU AU58344/86A patent/AU588883B2/en not_active Ceased
- 1986-06-04 PL PL1986259871A patent/PL146498B1/pl unknown
- 1986-06-04 FR FR8608039A patent/FR2582835B1/fr not_active Expired
- 1986-06-04 IT IT20667/86A patent/IT1204377B/it active
- 1986-06-04 GB GB08613530A patent/GB2176185B/en not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1753723B1 (en) | Substituted quinoline derivatives as mitotic kinesin inhibitors | |
US4296114A (en) | 3,4-Dihydro-3-oxopyrido[2,3-b]-pyrazines, compositions and use thereof | |
US6251900B1 (en) | Heterocyclic compounds and antitumor agent containing the same as active ingredient | |
Howard et al. | Hydrophobicity of several rhodium (II) carboxylates correlated with their biologic activity | |
US20070244110A1 (en) | Treatment of prostate cancer, melanoma or hepatic cancer | |
BR112018004175B1 (pt) | Composto pirazolo[3,4-d]pirimidina, composição farmacêutica, inibidor de her2 e agente antitumor contendo o dito composto e usos terapêuticos do dito composto | |
Brana et al. | Chromophore-modified bis-naphthalimides: synthesis and antitumor activity of bis-dibenz [de, h] isoquinoline-1, 3-diones | |
SE466308B (sv) | Kinolinderivat | |
PL128791B1 (en) | Process for manufacturing novel substituted bis-hydrazones-9,10-anthracene | |
US4782056A (en) | 2-phenylhexahydro-1,2,4-triazine-3-,5-diones | |
US3839347A (en) | 1-aminobenzimidazoles | |
Zalaru et al. | Synthesis and biological screening of some novel 2-(1H-pyrazol-1-yl)-acetamides as lidocaine analogue | |
Shablykin et al. | Synthesis and anticancer activity of new substituted imidazolidinone sulfonamides | |
US20100063118A1 (en) | Hydantoins Having RNase Modulatory Activity | |
Kajfez et al. | 1-Substitution in 2-methyl-4 (5)-nitroimidazole. I. Synthesis of compounds with potential antitrichomonal activity | |
US4866066A (en) | Thiomethylpyridine derivatives and their use for eliciting a bronchosecretolytic or mucolytic response | |
US4510307A (en) | 6-Quinazolinesulfonyl derivatives and process for preparation thereof | |
JPS61115069A (ja) | 複素環化合物 | |
US4273776A (en) | Antibacterial and antifungal derivatives of 3-(1H-imidazol-1-yl)-2-propen-1-ones | |
US4282230A (en) | Imidazolylethoxy derivatives of quinoline-2- or 4-methanols, antimicrobial compositions containing them and method for treating bacterial or fungal infections with them | |
US11000485B2 (en) | Substituted hydroxystilbenes as AhR and Nrf2 modulators and their therapeutic applications | |
US4218461A (en) | 2,3-Dihydro-2-[(1H-imidazol-1-yl)-methylene]-1H-inden-1-ones | |
Zoltewicz et al. | N-methylated 2, 3'-bipyridinium ion. First synthesis of the more sterically hindered isomer | |
US20240226096A1 (en) | Treatment of myeloproliferative diseases and disorders with inhibitors of bet family bdii bromodomain | |
US4317831A (en) | Antimicrobial derivatives of 3-(1H-imidazol-1-yl)-2-propen-1-ones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8602524-4 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 8602524-4 Format of ref document f/p: F |